Evidence map›Paper›PMID 42352481›Full record

ReviewCancers2026

Tumor-Treating Fields Plus Temozolomide Versus Temozolomide Alone in Newly Diagnosed Glioblastoma: A Systematic Review and Bayesian Meta-Analysis with Meta-Regression.

Plamen Penchev, Daniela Milanova-Ilieva, Lyubomir Gaydarski, Jorge Eduardo Alonso-Vera, Stefan Stavrevski, Petar-Preslav Petrov, Laurens Noack, Nikolai Ramadanov, Bogdana Suchorska

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Plamen PenchevFaculty of Medicine, Medical University of Plovdiv, 4001 Plovdiv, Bulgaria.ORCID 0009-0000-9942-9357
Daniela Milanova-IlievaDepartment of Pediatrics, St. George's University Hospital, 4002 Plovdiv, Bulgaria.ORCID 0009-0001-6762-3494
Lyubomir GaydarskiDepartment of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.ORCID 0000-0003-4774-6507
Jorge Eduardo Alonso-VeraFaculty of Medicine, Universidad Catolica de Santiago de Guayaquil, Guayaquil 090615, Ecuador.
Stefan StavrevskiClinic of Neurosurgery, University Hospital "St. Marina", 9010 Varna, Bulgaria.
Petar-Preslav PetrovDepartment of Anatomy, Histology, and Embryology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Laurens NoackCenter of Orthopaedics and Traumatology, Brandenburg Medical School, University Hospital Brandenburg, 14770 Brandenburg an der Havel, Germany.
Nikolai RamadanovCenter of Orthopaedics and Traumatology, Brandenburg Medical School, University Hospital Brandenburg, 14770 Brandenburg an der Havel, Germany.ORCID 0000-0003-4669-8187
Bogdana SuchorskaDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glioblastomaoverall survivalprogression-free survivaltemozolomidetumor-treating fields

Identifiers

PMID42352481
PMCPMC13297347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.